Market
Next state to file major opioid lawsuit against consulting firms by end of 2025?
2
Resolution / Starting Odds
California • 25%
New York • 25%
Texas • 25%
Other • 25%
Official announcements from state attorneys general or federal court records
Story
McKinsey to Pay $650 Million to Settle U.S. Opioid Investigation Linked to Purdue Pharma, Enters Deferred Prosecution Agreement
Dec 13, 2024, 02:58 PM
McKinsey & Company has agreed to pay $650 million to settle a U.S. Department of Justice investigation into its consulting work with Purdue Pharma, the maker of OxyContin. The settlement addresses allegations that McKinsey aided Purdue in boosting sales of opioid painkillers, contributing to the ongoing opioid crisis in the United States. As part of the resolution, McKinsey will enter into a five-year deferred prosecution agreement, which allows the firm to avoid criminal charges while acknowledging its role in the opioid epidemic. The settlement was announced during a news conference held at the Moakley Federal Courthouse in Boston, where federal prosecutors outlined the terms of the agreement. This resolution marks a significant moment in the broader legal scrutiny of consulting firms' involvement in the opioid crisis.
View original story
Similar markets
Other • 25%
Accenture • 25%
Deloitte • 25%
McKinsey & Company • 25%
Federal Trade Commission • 25%
Securities and Exchange Commission • 25%
U.S. Department of Justice • 25%
Other • 25%
Endo International • 25%
Johnson & Johnson • 25%
Other • 25%
Teva Pharmaceuticals • 25%
Other • 25%
CVS • 25%
Rite Aid • 25%
Walmart • 25%
$500 million to $1 billion • 25%
Less than $500 million • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Walmart • 25%
None of the above • 25%
Rite Aid • 25%
Walgreens • 25%
